MedPath

Ayurvedic medicine for Obesity

Phase 2/3
Not yet recruiting
Conditions
Obesity, unspecified. Ayurveda Condition: STHAULYA,
Registration Number
CTRI/2021/12/038822
Lead Sponsor
Dr Ruddri Raval
Brief Summary

The study is to evaluate  the efficacy of Novel Ayurveda Products in sthaulya (obesity) when administered for 30 days at dose 2 tab and 2 capsule BD before meal .

The expected outcome is Novel Ayurveda Products will be effective in Sthaulya (obesity)

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

1.Patients from either sex with classical sign and symptoms of Sthaulya 2.Patients of age group 20 to 50 years 3.Patients with BMI greater than or equal to 30 kg per meter square.

Exclusion Criteria
  • 1.Patients below 20 and above 50 years of age 2.
  • Patients having major systemic disorders or other illnesses such as Hypothyroidism Cushing syndrome Hypersensitivity and Diabetes which interfere with the present study 3.Patients with serious disease limiting life expectancy 4.Pregnancy and lactating mothers 5.Cognitive impairment congenital deformities 6.Not willing to participate in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Novel Ayurveda Products will be effective in Sthaulya (obesity)baseline and on 30th day
Secondary Outcome Measures
NameTimeMethod
1.serum insulin2.HsCRP levels

Trial Locations

Locations (1)

KAHERS Shri BM Kankanwadi Ayurveda Mahavidyalaya and Hospital

🇮🇳

Belgaum, KARNATAKA, India

KAHERS Shri BM Kankanwadi Ayurveda Mahavidyalaya and Hospital
🇮🇳Belgaum, KARNATAKA, India
Dr Ruddri Raval
Principal investigator
9428000175
kw0120008-t@kleayurworld.edu.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.